Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

BUY
$59.54 - $68.01 $604,569 - $690,573
10,154 Added 9.27%
119,749 $7.39 Million
Q2 2022

Aug 02, 2022

BUY
$57.72 - $65.01 $207,561 - $233,775
3,596 Added 3.39%
109,595 $6.77 Million
Q1 2022

May 03, 2022

BUY
$57.92 - $72.58 $6.14 Million - $7.69 Million
105,999 New
105,999 $6.3 Million
Q4 2018

Feb 14, 2019

SELL
$60.54 - $79.0 $276,001 - $360,161
-4,559 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$71.28 - $78.92 $376,857 - $417,250
-5,287 Reduced 53.7%
4,559 $330,000
Q2 2018

Aug 22, 2018

BUY
$64.88 - $75.68 $332,964 - $388,389
5,132 Added 108.87%
9,846 $697,000
Q1 2018

Jun 25, 2018

BUY
$72.84 - $88.8 $343,367 - $418,603
4,714 New
4,714 $355,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Mount Yale Investment Advisors, LLC Portfolio

Follow Mount Yale Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.